Study examines ethical dilemmas of medical tourism

Posted In: Policy & Industry

By EurekAlert

Wednesday, October 7, 2009

Loading...

This press release is available in French.

Montreal, October 7, 2009 - Medical tourism in Latin America needs to be regulated to protect consumers, according to Université de Montréal researchers. A new study published in the journal Developing World Bioethics argues that Argentinean fertility clinics are increasingly marketing themselves to international health care consumers: these clinics offer all-inclusive packages with fixed prices that feature airfare, accommodations, transfers, language interpreters and, of course, fertility treatments.

"The appeal of such packages is obvious: healthcare consumers need not worry about any of the practical details of their trip - budgeting, travel arrangements or language barriers - and can instead focus on obtaining quality medical services combined with a vacation. Non-accredited clinics in Argentina offer much more competitive prices for services in comparison with clinics in North America or Europe. For example, in vitro fertilization in the United States runs upwards of $10,000 U.S. per cycle of treatment," says Bryn Williams-Jones, a bioethics professor in the Université de Montréal's Department of Social and Preventive Medicine, who coauthored the paper with graduate students Elise Smith, Carolina Martin and Jason Behrmann.

An increasing number of private fertility clinics have opened in developing countries such as Argentina over the last decade and are attracting consumers through lower pricing. There are two subcategories of medical tourism clinics: accredited centres that are part of the broader healthcare industry and non-accredited clinics focused on medical tourism. "While the 'big players' in medical tourism, such as India and Poland, are actively involved in the fertility sector, so too now are Latin American countries such as Brazil, Chile, Mexico and Argentina," says Dr. Williams-Jones.

Reproductive tourism clinics are targeting wealthy North American or European couples through the Internet. "The main interest for these individuals to become medical tourists is the high cost, long waiting lists, or even the absence of access assisted reproductive technologies services at home," says Dr. Williams-Jones.

Developed and developing nations have encouraged the practice of medical tourism, the authors argue, because of the economic spinoffs. Legislation and professional guidelines - both local and international - are needed to regulate the conduct of private fertility clinics in order to ensure that services are safe and effective. "It is in the best interests of consumers, health professionals and policy makers that the reproductive tourism industry adopts safe and responsible medical practices," says Dr. Williams-Jones.

SOURCE

JOIN THE DISCUSSION
Rate Article:  Average 0 out of 5
Register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

New To Market

more

P2i showcases liquid repellent nano-coating for hearing aids
P2i showcases liquid repellent nano-coating for hearing aids

At the AudiologyNOW! 2010 show in San Diego next month, UK-based coatings company P2i will display their relatively new Aridion liquid-repellant nano-coating. Designed for exposure to humidity or sweat, the polymer layer is applied by a pulsed ion gas process that lower’s the hearing aid’s surface energy, coaxing water away from delicate components.

Submersible FlowCAM catches particle images and data in-situ and real-time

Fluid Imaging Technologies recently introduced its Submersible FlowCAM particle and cell imaging and analysis system at Ocean Sciences 2010 in Portland, Ore. The remote sensing platform can be used for continuous, unattended monitoring tethered to research vessels or autonomous submersibles.

Tools & Technology

more

Benchtop NMR analyzer
Benchtop NMR analyzer

Oxford Instruments America, Inc.’s Magnetic Resonance Group released the second generation of its MQC analyzers.

Software solution for microarray image analysis

BioDiscovery Inc. released ImaGene 9.0 for microarray image analysis. The new features include improved memory performance for the latest high density arrays, streamlined processing pipeline focused on image quantification and intensity extraction, and new modular design with options to add modules for analysis of gene/miRNA expression or CGH data.

Advertisement

Advertisement